StonvexLoading…
StonvexStonvexStonvexCore line items from DCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-07-31 | Annual 2024 2024-07-31 | Annual 2023 2023-07-31 | Annual 2022 2022-07-31 |
|---|---|---|---|---|
Revenue | $3.69B | $3.59B | $3.43B | $3.31B |
Operating Income | $495.40M | $544.10M | $480.20M | $443.50M |
Net Income | $367.00M | $414.00M | $358.80M | $332.80M |
EPS (Diluted) | $3.05 | $3.38 | $2.90 | $2.66 |
Total Assets | $2.98B | $2.91B | $2.77B | $2.60B |
Total Liabilities | $1.52B | $1.43B | $1.45B | $1.47B |
Cash & Equivalents | $180.40M | $232.70M | $187.10M | $193.30M |
Free Cash Flow OCF − CapEx | $339.90M | $406.90M | $426.00M | $167.30M |
Shares Outstanding | 120.40M | 122.60M | 123.60M | 125.20M |